PET-CT for assessment of multiple myeloma disease burden and metabolic response before and after carfilzomib- based induction, consolidation and carfilzomib maintenance therapy: data from the UK NCRI Cardamon Study
Authors
Bygrave, C. A.Subesinghe, M.
Wilson, W.
Popat, R.
Ramasamy, K.
Pang, G.
Jenner, R.
Kamora, S.
Dadaga, T.
Pike, L.
Streetly, M.
Camilleri, M.
Owen, R. G.
Cavenagh, J.
Sive, J.
Chapman, M.
Phillips, Elizabeth H
Chavda, S. J.
del MarCuadrado, M.
Benjamin, R.
Eccersley, L.
Moore, S.
Banerjee, L.
Clifton-Hadley, L.
Barrington, S. F.
Yong, K.
Affiliation
Department of Haematology, University Hospital of Wales, CardiffIssue Date
2021
Metadata
Show full item recordCitation
Bygrave CA, Subesinghe M, Wilson W, Popat R, Ramasamy K, Pang G, et al. PET-CT for Assessment of Multiple Myeloma Disease Burden and Metabolic Response before and after Carfilzomib- Based Induction, Consolidation and Carfilzomib Maintenance Therapy: Data from the UK NCRI Cardamon Study. Blood. 2021 Nov;138. PubMed PMID: WOS:000736413903048.Journal
BloodDOI
10.1182/blood-2021-150177Additional Links
https://dx.doi.org/10.1182/blood-2021-150177Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2021-150177